Uncategorized Archives - Compliance Insight

January 16, 2023by t_king

What is an Unique Device Identifier (UDI)?

December 23, 2022by t_king

Happy holidays one and all!!

August 2, 2022by t_king

Goodness Gracious, Great Balls of Fire!

July 5, 2022by t_king

FDA Urges Drug Manufacturers to Implement Stronger Risk Management Plans

June 28, 2022by t_king

What is an UDI and why does it matter?

June 16, 2022by t_king

FDA authorizations for EUAs

Medical-Devices-scaled

June 7, 2022by t_king

The FDA Is Adopting ISO 13485: What This Means for Medical Devices

Baby milk formula on kitchen background

June 2, 2022by t_king

FDA Announces Increased Flexibilities Regarding Importation of Infant Formula

May 27, 2022by t_king

Happy Memorial Day

April 7, 2022by t_king

Compliance Insight Named Top 10

December 21, 2021by t_king

Season’s Greetings

November 24, 2021by t_king

Happy Thanksgiving from Compliance Insight

November 10, 2021by t_king

How do you know that you are in control?

October 19, 2021by t_king

Xavier Artificial Intelligence (AI) Summit

October 13, 2021by t_king

Did you hear about the latest FDA press release?

September 29, 2021by t_king

GMP Training

Pharma BA BE

September 21, 2021by Brittany Wells

Policy for the Quantity of BA & BE Samples

Cybersecurity

September 14, 2021by Brittany Wells

Cybersecurity in pharmaceutical industry

What is a Genetic Diease

September 7, 2021by Brittany Wells

Do you know what a genetic disease is?

September 3, 2021by Brittany Wells

AI in Pharma Adoption, Part 5: AI Value in Complex, Unstructured and Multiparametric Data

August 31, 2021by Brittany Wells

FDA Encourages Inclusion of Patients with Incurable Cancers in Oncology Clinical Trials Regardless of Prior Therapies